BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,022 | -17.2% | 5,300 | 0.0% | 0.01% | -21.4% |
| Q2 2023 | $241,468 | +12.3% | 5,300 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $214,968 | -20.4% | 5,300 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $270,141 | -5.2% | 5,300 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $285,000 | -16.2% | 5,300 | 0.0% | 0.02% | -13.0% |
| Q2 2022 | $340,000 | -17.3% | 5,300 | 0.0% | 0.02% | +4.5% |
| Q1 2022 | $411,000 | -9.7% | 5,300 | 0.0% | 0.02% | +10.0% |
| Q4 2021 | $455,000 | +6.8% | 5,300 | 0.0% | 0.02% | -9.1% |
| Q3 2021 | $426,000 | -0.2% | 5,300 | 0.0% | 0.02% | +10.0% |
| Q2 2021 | $427,000 | -4.5% | 5,300 | 0.0% | 0.02% | -13.0% |
| Q1 2021 | $447,000 | -45.9% | 5,300 | -48.5% | 0.02% | -53.1% |
| Q4 2020 | $826,000 | -0.2% | 10,300 | 0.0% | 0.05% | -30.0% |
| Q3 2020 | $828,000 | -6.7% | 10,300 | 0.0% | 0.07% | -13.6% |
| Q2 2020 | $887,000 | +6.1% | 10,300 | 0.0% | 0.08% | -19.8% |
| Q1 2020 | $836,000 | -2.9% | 10,300 | 0.0% | 0.10% | +53.0% |
| Q4 2019 | $861,000 | -4.4% | 10,300 | 0.0% | 0.07% | -18.5% |
| Q3 2019 | $901,000 | +6.8% | 10,300 | 0.0% | 0.08% | +5.2% |
| Q2 2019 | $844,000 | +0.8% | 10,300 | 0.0% | 0.08% | +4.1% |
| Q1 2019 | $837,000 | +23.5% | 10,300 | 0.0% | 0.07% | +10.4% |
| Q4 2018 | $678,000 | -14.6% | 10,300 | 0.0% | 0.07% | +8.1% |
| Q3 2018 | $794,000 | +2.5% | 10,300 | -1.9% | 0.06% | 0.0% |
| Q2 2018 | $775,000 | +13.5% | 10,500 | 0.0% | 0.06% | +6.9% |
| Q1 2018 | $683,000 | +0.6% | 10,500 | 0.0% | 0.06% | 0.0% |
| Q4 2017 | $679,000 | +3.0% | 10,500 | 0.0% | 0.06% | +1.8% |
| Q3 2017 | $659,000 | +3.6% | 10,500 | 0.0% | 0.06% | 0.0% |
| Q2 2017 | $636,000 | +16.7% | 10,500 | 0.0% | 0.06% | +11.8% |
| Q1 2017 | $545,000 | +17.0% | 10,500 | 0.0% | 0.05% | +13.3% |
| Q4 2016 | $466,000 | -14.8% | 10,500 | -8.7% | 0.04% | -21.1% |
| Q3 2016 | $547,000 | -2.5% | 11,500 | -7.3% | 0.06% | -16.2% |
| Q2 2016 | $561,000 | +30.2% | 12,412 | +18.2% | 0.07% | +36.0% |
| Q1 2016 | $431,000 | +7.5% | 10,500 | 0.0% | 0.05% | +11.1% |
| Q4 2015 | $401,000 | +16.2% | 10,500 | 0.0% | 0.04% | +7.1% |
| Q3 2015 | $345,000 | -53.0% | 10,500 | 0.0% | 0.04% | -44.7% |
| Q2 2015 | $734,000 | +2.1% | 10,500 | 0.0% | 0.08% | +2.7% |
| Q1 2015 | $719,000 | -6.6% | 10,500 | 0.0% | 0.07% | -2.6% |
| Q4 2014 | $770,000 | +2.1% | 10,500 | 0.0% | 0.08% | +20.6% |
| Q3 2014 | $754,000 | -0.7% | 10,500 | 0.0% | 0.06% | +12.5% |
| Q2 2014 | $759,000 | +8.6% | 10,500 | +10.5% | 0.06% | +9.8% |
| Q1 2014 | $699,000 | +5.7% | 9,500 | 0.0% | 0.05% | +27.5% |
| Q4 2013 | $661,000 | -19.5% | 9,500 | -24.0% | 0.04% | -20.0% |
| Q3 2013 | $821,000 | -6.0% | 12,500 | -0.8% | 0.05% | +22.0% |
| Q2 2013 | $873,000 | – | 12,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |